Annals of Surgical Oncology Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
10.1245/s10434-007-9461-1
Annals of Surgical Oncology 14:2543-2549 (2007)
© 2007 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kosaka, Y.
Right arrow Articles by Mori, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kosaka, Y.
Right arrow Articles by Mori, M.

Original Article

Tripartite Motif-Containing 29 (TRIM29) Isa Novel Marker for Lymph Node Metastasis in Gastric Cancer

Yoshimasa Kosaka, MD1,2, Hiroshi Inoue, MD, PhD1, Takahiro Ohmachi, MD1, Takeshi Yokoe, MD1, Toshifumi Matsumoto, MD, PhD1, Koshi Mimori, MD, PhD1, Fumiaki Tanaka, MD, PhD1, Masahiko Watanabe, MD, PhD2 and Masaki Mori, MD, PhD, FACS1

1 Department of Surgical Oncology, Medical Institute of Bioregulation, Kyushu University, 4546, Tsurumihara, Beppu, 874-0838, Japan
2 Department of Surgery, Kitasato University School of Medicine, 1-15-1 Kitasato, Sagamihara, 228-8555, Japan

Correspondence: Address correspondence and reprint requests to: Masaki Mori, MD, PhD, FACS; E-mail: mmori{at}beppu.kyushu-u.ac.jp

Background: Tripartite motif-containing 29 (TRIM29) belongs to the TRIM protein family, which has unique structural characteristics, including multiple zinc finger motifs and a leucine zipper motif. TRIM29, also known as ataxia telangiectasia group D complementing gene, possesses radiosensitivity suppressor functions. Although TRIM29 has been reported to be underexpressed in prostate and breast cancer, its expression in gastrointestinal cancer has not been studied.

Methods: By use of real-time reverse transcriptase–polymerase chain reaction, we analyzed TRIM29 mRNA expression status with respect to various clinicopathological parameters in 124 patients with gastric cancer. An immunohistochemical study was also conducted.

Results: The expression of TRIM29 was far higher in gastric cancer tumor tissue. Increased TRIM29 mRNA expression was markedly associated with such parameters as histological grade, large tumor size, extent of tumor invasion, and lymph node metastasis. In the TRIM29 high-expression group, it was an independent predictor for lymph node metastasis. Furthermore, patients with high TRIM29 mRNA expression showed a far poorer survival rate than those with low TRIM29 mRNA expression.

Conclusions: TRIM29 expression may serve as a good marker of lymph node metastasis in gastric cancer.

Key Words: ATDC • Gastric cancer • Lymph node metastasis • Prognosis • TRIM29






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Society of Surgical Oncology.